ASSESS supports health technology innovators and startups
Discover how a global network of experts can support your organization to achieve key milestones, including making foundational strategic decisions, achieving investment, obtaining trial, and securing adoption.
Explore commercialization milestones
Your Milestones
Which milestones in your commercialization journey can ASSESS help you achieve next?
Foundational decisions determine technology commercial potential and probability of success.
ASSESS supports innovators with key insights at a time when there is opportunity to make decisions that focus R&D, commercialization, and evidence generation efforts on those that have the highest value from the perspective of the payer and end user.
See an interactive early economic evaluation example →Experience
Some companies we've worked with across the health technology landscape
Your Questions
What key questions in your commercialization journey can ASSESS help you answer?
At each stage of the Commercialization Journey, life sciences innovators have key questions that can be answered with support of those with expertise in health technology assessment and health economics.
What is the most valuable lead or beachhead clinical application for the technology?
What is the technology commercial potential and evidence requirements to bring to market?
What is the potential for the technology to be attractive to payers, and at what price?
How can health systems be engaged to trial technology, and how can trials be structured to effectively prove economic value?
How can data from trial be analyzed and packaged for submission to procurement?
Testimonials
What our clients say
"We are extremely satisfied with the work done and have already recommended the service to others. This program has been invaluable to us - this kind of evidence is vital to digital health sales and incredibly hard to find."
Rob Attwell
COO, CareTeam
"The ASSESS project provided NURA with robust, real-world data to substantiate the health economic rationale underlying our pricing structure. This data will be instrumental in presenting our value proposition to hospital decision-makers and investors."
Georgia Powell
Co-founder & CEO, Nura Medical
"Our team was very happy with the level of thoroughness and rigor of the work and deliverables from the ASSESS team, as well as their communication. We would recommend the service to other organizations."
Tanya Scarapicchia
Greenspace
"The economic evaluation that was conducted helped with initial conversations with our investors and it ultimately led to the closure of our first financing round."
Saumik Biswas
CEO, Founder, Tenomix
"The economic modeling report is a foundational tool that supports our firm's growth by providing data-driven insights for investors, internal decision-makers, and potential clients."
Cindy Sim
CEO, CarePal
"We enjoyed working with and recommend ASSESS. They helped us to complete an early economic analysis to assist us to demonstrate that our product is extremely cost effective in our target population."
Rory St. Clair
VP Operations, Proton
Why Us
First-in-World approach
For the first time, ASSESS has created a mechanism to enable a global network of accomplished experts to contribute to the commercialization success of innovative companies, ensuring the right skill set, experience, target market and therapeutic area knowledge is matched to the support needs of innovators.
A global community of leading experts assembled to support innovative companies
ASSESS has assembled an online global community of those with expertise and experience in assessing and modelling the value of new technologies, how they can integrate into complex care pathways, and the evidence required for patients to gain access to them.
Collaboration
Work together across all phases of your journey
The intent for ASSESS is to engage and to work continuously with innovators, in a longitudinal fashion, providing services and guidance from different types of expertise of the assembled community as the technology matures.
Our Network
Building a worldwide partner network
We are building a worldwide network of partners that contribute to the success of innovative companies, including grant funding, investor, and trial networks.
ASSESS's services are supported in part by funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).
Want to explore engaging with ASSESS?
Contact us to share the milestones you require support to achieve, or to answer the burning questions you have, and to understand how we can help.